Amgen/ US0311621009 /

8/10/2022 9:59:59 PM	Chg. +3.64	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
252.05USD	+1.47%	123,946 Turnover: 31.06 mill.	-Bid Size: -	-Ask Size: -	134.85 bill.USD	2.79%	24.38

TeleTrader 8/4 Amgen's Q2 EPS triples to $2.45

TeleTrader 8/4 US closes mostly lower after labor market data

TeleTrader 8/4 US opens mostly flat after trade, jobs data

TeleTrader 6/2 Wall Street opens lower amid data

GlobeNewswire 3/25 U.S. Naval Academy Announces 2021 Distinguished Graduate Awardees

GlobeNewswire 3/23 CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors

GlobeNewswire 3/23 OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Bio...

GlobeNewswire 3/21 Vivacitas Oncology Appoints Harvard Professor of Medicine Dr. David Reardon, MD to the Company's Neu...

GlobeNewswire 3/21 Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors

GlobeNewswire 3/17 CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program...

GlobeNewswire 3/16 C4 Therapeutics Appoints Utpal Koppikar to Board of Directors

GlobeNewswire 3/15 Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021

GlobeNewswire 3/15 Coherus BioSciences Appoints Rosh Dias, MD, MRCP, Chief Medical Officer

GlobeNewswire 3/15 Epygenix Therapeutics Announces Appointment of Darren Cline as CEO

GlobeNewswire 3/14 OcyonBio Announces Biosimilar Solutions to Begin GMP Manufacturing in Puerto Rico

GlobeNewswire 3/9 Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors

GlobeNewswire 3/8 Entera Bio Reports Financial Results for the Year Ended December 31, 2021

GlobeNewswire 3/7 Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory Board

GlobeNewswire 3/3 IO Biotech Announces Appointment of David V. Smith to its Board of Directors

GlobeNewswire 3/3 Entera Bio to Report Business and Financial Results for the Year Ended December 31, 2021 on March 8,...

GlobeNewswire 3/2 AmMax Bio Announces Positive Phase 2 Results Demonstrating Proof-of-Concept for the Novel Local Deli...

GlobeNewswire 3/1 CytomX Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Busine...

GlobeNewswire 3/1 Fight Colorectal Cancer is demanding MORE from Congress this March

GlobeNewswire 3/1 Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commerci...

GlobeNewswire 2/28 Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corpor...